Per Os Acetaminophen — Competitive Intelligence Brief

Per Os Acetaminophen (Per Os Acetaminophen) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-opioid analgesic and antipyretic. Area: Pain Management.

marketed Non-opioid analgesic and antipyretic Cyclooxygenase (COX), primarily in central nervous system Pain Management Small molecule

Target snapshot

Per Os Acetaminophen (Per Os Acetaminophen) — Hospital for Special Surgery, New York. Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Per Os Acetaminophen TARGET	Per Os Acetaminophen	Hospital for Special Surgery, New York	marketed	Non-opioid analgesic and antipyretic	Cyclooxygenase (COX), primarily in central nervous system
Placebo to Acetaminophen/Paracetamol	Placebo to Acetaminophen/Paracetamol	Merck Sharp & Dohme LLC	phase 3	Non-opioid analgesic and antipyretic	Cyclooxygenase (COX)
Metamizole and Acetaminophen iv	Metamizole and Acetaminophen iv	Hospital General Universitario Elche	phase 3	Non-opioid analgesic and antipyretic combination	Cyclooxygenase (COX) enzymes; central pain and temperature regulation pathways

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Non-opioid analgesic and antipyretic class)

1. Hospital for Special Surgery, New York · 1 drug in this class
2. Merck Sharp & Dohme LLC · 1 drug in this class